Integrated Analysis of Droxidopa for the Treatment of Neurogenic Orthostatic Hypotension in Patients with Parkinson Disease
Sign Up to like & getrecommendations! Published in 2018 at "Movement Disorders Clinical Practice"
DOI: 10.1002/mdc3.12695
Abstract: Neurogenic orthostatic hypotension (nOH) is associated with neurodegenerative conditions, may cause symptoms of end‐organ hypoperfusion, increases fall risk, and can negatively impact quality of life. Droxidopa is approved for the treatment of symptomatic nOH in… read more here.
Keywords: treatment; parkinson disease; droxidopa; orthostatic hypotension ... See more keywords
Simultaneous voltammetric determination of droxidopa, acetaminophen, and tyrosine on hematoxylin and graphene oxide/ZnO nanocomposite-modified glassy carbon electrode
Sign Up to like & getrecommendations! Published in 2017 at "Ionics"
DOI: 10.1007/s11581-017-2316-2
Abstract: Hematoxylin was used in combination with graphene oxide/ZnO nanocomposites as the adhesives for fabricating sensitivity-enhanced electrochemical droxidopa sensor. The electrochemical method showed an excellent character for electrocatalytic oxidization of droxidopa in the presence of acetaminophen… read more here.
Keywords: graphene oxide; droxidopa; acetaminophen tyrosine; determination droxidopa ... See more keywords
Durability of the Clinical Benefit of Droxidopa for Neurogenic Orthostatic Hypotension During 12 Weeks of Open-Label Treatment
Sign Up to like & getrecommendations! Published in 2022 at "Neurology and Therapy"
DOI: 10.1007/s40120-021-00317-5
Abstract: Introduction Droxidopa is approved to treat neurogenic orthostatic hypotension (nOH) symptoms in patients with autonomic failure based on short-term clinical trial data. Additional data on the long-term efficacy of droxidopa are needed. We have evaluated… read more here.
Keywords: orthostatic hypotension; treatment; droxidopa; open label ... See more keywords
The effect of ultrasonic irradiation on the morphology of NiO/Co3O4 nanocomposite and its application to the simultaneous electrochemical determination of droxidopa and carbidopa.
Sign Up to like & getrecommendations! Published in 2019 at "Ultrasonics sonochemistry"
DOI: 10.1016/j.ultsonch.2019.04.002
Abstract: The present work deals with the preparation of NiO/Co3O4 nanocomposites in presence of ultrasonic irradiation, and its use in electrochemical determination of Parkinson's drugs. NiO/Co3O4 nanocomposites are prepared using ultrasound assisted method. The impact of… read more here.
Keywords: nio co3o4; droxidopa; ultrasonic irradiation; co3o4 ... See more keywords
Droxidopa in the Management of Hepatorenal Syndrome.
Sign Up to like & getrecommendations! Published in 2022 at "Journal of pharmacy practice"
DOI: 10.1177/08971900221087974
Abstract: PURPOSE Hepatorenal syndrome (HRS) is renal dysfunction associated with the hemodynamic consequences of advanced liver disease and cirrhosis. HRS is associated with a high mortality, and there remain high failure rates with first-line therapy aimed… read more here.
Keywords: times daily; droxidopa; three times; management ... See more keywords
Droxidopa Persistence in Neurogenic Orthostatic Hypotension May Be Affected by Titration Approach
Sign Up to like & getrecommendations! Published in 2021 at "International Journal of General Medicine"
DOI: 10.2147/ijgm.s304012
Abstract: Abstract Droxidopa is approved for the treatment of neurogenic orthostatic hypotension (nOH) symptoms and requires patients to be titrated to individualized effective doses (100–600 mg, three times daily) based on symptomatic response. As per the… read more here.
Keywords: persistence; maintenance; droxidopa; titration ... See more keywords